HR Execs on the Move

Clario

www.clario.com

 
Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Clario`s global team of science, technology and operational experts have helped deliver more than 27,000 trials and contributed to over 500 FDA and EMEA new drug approvals involving more ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.clario.com
  • 1818 Market Street Suite 2600
    Philadelphia, PA USA 19103
  • Phone: 215.972.0420

Executives

Name Title Contact Details
Lisa Annunziata
 Director, Human Resources Profile
Stephane Lebeau
 VP, HR M&A and Organizational Effectiveness Profile
Jason Knoblauch
 Chief Financial Officer Profile
David Fusco
 Executive Vice President and Chief Human Capital Officer Profile

Similar Companies

Zafgen

Zafgen, a biopharmaceutical company, develops obesity therapeutics that help the body regain and sustain a lean and healthy state.

Lifesprout

Revolutionary Products for Soft Tissue Replacement and Regeneration

GangaGen Inc

GangaGen Inc is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Synthego

Synthego is a leading provider of genome engineering solutions. Our flagship product, CRISPRevolution, is a portfolio of synthetic guide RNA designed for CRISPR genome editing and research. Synthego`s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.

Enveda Biosciences

At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature`s complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics.